P.B. Clinical Research Limited 07772118 false 2022-10-01 2023-09-30 2023-09-30 The principal activity of the company is Consultancy services Digita Accounts Production Advanced 6.30.9574.0 true 07772118 2022-10-01 2023-09-30 07772118 2023-09-30 07772118 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 07772118 bus:Micro-entities 2022-10-01 2023-09-30 07772118 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 07772118 bus:FullAccounts 2022-10-01 2023-09-30 07772118 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 07772118 bus:RegisteredOffice 2022-10-01 2023-09-30 07772118 bus:Director1 2022-10-01 2023-09-30 07772118 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 07772118 countries:UnitedKingdom 2022-10-01 2023-09-30 07772118 2021-10-01 2022-09-30 07772118 2022-09-30 07772118 core:CurrentFinancialInstruments core:WithinOneYear 2022-09-30 iso4217:GBP xbrli:pure

Registration number: 07772118

P.B. Clinical Research Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2023

 

P.B. Clinical Research Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

P.B. Clinical Research Limited

Company Information

Director

Mrs Pippa Bannister

Registered office

Swyllmers
The Lee
Great Missenden
Bucks
HP16 9NA

Accountants

AIMS Accountants for Business
36 Wattleton Road
Beaconsfield
Bucks
HP9 1SE

 

P.B. Clinical Research Limited

(Registration number: 07772118)
Balance Sheet as at 30 September 2023

2023
£

2022
£

Fixed assets

3,957

2,678

Current assets

138,197

93,016

Creditors: Amounts falling due within one year

(21,602)

(7,299)

Net current assets

116,595

85,717

 

120,552

88,395

Capital and reserves

120,552

88,395

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Swyllmers
The Lee
Great Missenden
Bucks
HP16 9NA

These financial statements were authorised for issue by the director on 19 April 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

For the financial year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

P.B. Clinical Research Limited

(Registration number: 07772118)
Balance Sheet as at 30 September 2023

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 19 April 2024
 

.........................................
Mrs Pippa Bannister
Director